UNIVEST FINANCIAL Corp
For the period ended Dec 31, 2025. Filed Feb 23, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 23, 2026
UVSP$40.83-0.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
| For the Years Ended December 31, | |||
|---|---|---|---|
| (Dollars in thousands) | 2025 | 2024 | 2023 |
| Cash flows from operating activities: | |||
| Net income | $90,757 | $75,931 | $71,104 |
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Provision for credit losses | 11,667 | 5,933 | 10,770 |
| Depreciation of premises and equipment | 5,505 | 5,473 | 5,057 |
| Net gain on sales of investment securities | — | (18) | — |
| Net gain on mortgage banking activities | (3,362) | (5,265) | (3,689) |
| Bank owned life insurance income | (5,849) | (3,861) | (3,185) |
| Net amortization of investment securities premiums and discounts | 968 | 1,058 | 1,138 |
| Amortization, fair market value adjustments and capitalization of servicing rights | 512 | 1,993 | (411) |
| Stock-based compensation | 4,690 | 4,615 | 4,194 |
| Intangible expenses | 469 | 694 | 938 |
| Other adjustments to reconcile net income to cash used in by operating activities | (4,412) | (3,362) | (1,462) |
| Deferred tax expense (benefit) | 508 | (1,271) | (710) |
| Originations of loans held for sale | (213,609) | (309,506) | (228,532) |
| Proceeds from the sale of loans held for sale | 217,811 | 311,150 | 226,506 |
| Contributions to pension and other postretirement benefit plans | (257) | (243) | (250) |
| Decrease (increase) in accrued interest receivable and other assets | 2,136 | (12,020) | (8,877) |
| (Decrease) increase in accrued interest payable and other liabilities | (6,022) | 3,805 | 17,150 |
| Net cash provided by operating activities | 101,512 | 75,106 | 89,741 |
| Cash flows from investing activities: | |||
| Proceeds from sale of premises and equipment | 411 | 2,367 | 1,877 |
| Purchases of premises and equipment | (4,585) | (3,104) | (6,724) |
| Proceeds from maturities, calls and principal repayments of securities held-to-maturity | 13,308 | 13,949 | 14,799 |
| Proceeds from maturities, calls and principal repayments of securities available-for-sale | 54,821 | 55,873 | 30,738 |
| Proceeds from sales of securities available-for-sale | — | 505 | — |
| Purchases of investment securities held-to-maturity | (2,546) | (2,640) | (6,253) |
| Purchases of investment securities available-for-sale | (51,315) | (64,017) | (25,132) |
| Proceeds from sales of equity securities | 6,940 | 4,944 | 1,232 |
| Purchases of money market mutual funds | (6,448) | (4,089) | (1,963) |
| Net decrease (increase) in other investments | 1,172 | 1,519 | (6,658) |
| Proceeds from sale of loans originally held-for-investment | — | — | 25,450 |
| Net increase in loans and leases | (100,961) | (260,981) | (474,200) |
| Proceeds from sales of foreclosed / repossessed assets | 322 | 80 | 260 |
| Purchases of bank owned life insurance | — | (5,710) | (7,862) |
| Proceeds from bank owned life insurance | 5,199 | 1,563 | — |
| Net cash used in investing activities | (83,682) | (259,741) | (454,436) |
| Cash flows from financing activities: | |||
| Net increase in deposits | 328,051 | 383,458 | 462,229 |
| Net increase (decrease) in short-term borrowings | 13,230 | 4,875 | (190,835) |
| Proceeds from issuance of long-term debt | 50,000 | — | 250,000 |
| Repayment of long-term debt | (75,000) | (85,000) | (35,000) |
| Proceeds from issuance of subordinated notes | 50,000 | — | — |
| Subordinated notes issuance costs | (802) | — | — |
| Repayment of subordinated notes | (100,000) | — | — |
| Payment of contingent consideration on acquisitions | (635) | (635) | (635) |
| Payment for shares withheld to cover taxes on vesting of restricted stock units | (1,611) | (873) | (1,232) |
| Purchases of treasury stock | (34,625) | (18,882) | (462) |
| Stock issued under dividend reinvestment and employee stock purchase plans | 2,316 | 2,384 | 2,565 |
| Proceeds from exercise of stock options | 1,448 | 3,195 | 115 |
| Cash dividends paid | (25,334) | (24,842) | (25,050) |
| Net cash provided by financing activities | 207,038 | 263,680 | 461,695 |
| Net increase in cash and cash equivalents | 224,868 | 79,045 | 97,000 |
|---|---|---|---|
| Cash and cash equivalents at beginning of year | 328,844 | 249,799 | 152,799 |
| Cash and cash equivalents at end of period | $553,712 | $328,844 | $249,799 |
| For the Years Ended December 31, | |||
| 2025 | 2024 | 2023 | |
| Supplemental disclosures of cash flow information: | |||
| Cash paid for interest | $200,413 | $191,513 | $139,600 |
| Non cash transactions: | |||
| Transfer of loans to other real estate owned | $3,945 | $407 | $79 |
| Transfer of leases to repossessed assets | 143 | 181 | — |
| Transfer of loans to loans held for sale | — | — | 25,646 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.